|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01515 CR MEDICAL
Nominal 
3.950 +0.060 (+1.542%) | 2024/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | 2021/06 RMB(K¥) | 2020/06 RMB(K¥) | |
| Turnover | 4,976,334 | -2.692% | 5,114,026 | 3,205,932 | 1,772,123 | 907,413 |
| Cost of Sales | (3,939,986) | -2.106% | (4,024,751) | (2,600,472) | (1,377,549) | (662,090) |
| Gross Profit | 1,036,348 | -4.859% | 1,089,275 | 605,460 | 394,574 | 245,323 |
| 2024/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | 2021/06 RMB(K¥) | 2020/06 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | 1,465 | -- | (4,282) | (3,238) | 796 | (6,669) | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 44,329 | 6.742% | 41,529 | 31,209 | 43,714 | 404 | |
| Profit / (Loss) before Taxation | 627,328 | 0.352% | 625,126 | 313,961 | 270,142 | 156,191 | |
| Taxation | (115,673) | -16.335% | (138,258) | (43,365) | (64,817) | (45,971) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | (77,706) | -12.877% | (89,191) | (25,927) | (6,010) | (2,467) | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 433,949 | 9.121% | 397,677 | 244,669 | 199,315 | 107,753 | |
| 2024/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | 2021/06 RMB(K¥) | 2020/06 RMB(K¥) | |
| Net Finance Costs / (Income) | 31,618 | 0.308% | 31,521 | 3,091 | 5,878 | 9,343 |
| Depreciation & Amortisation | 302,722 | 4.587% | 289,444 | 188,062 | 68,291 | 47,523 |
| Directors' Emoluments | -- | -- | -- | -- | -- | -- |
| 2024/06 - Interim | %Chg (Compare to Interim) | 2023/06 | 2022/06 | 2021/06 | 2020/06 | |
| Auditor's Opinion Status | N/A | -- | N/A | N/A | N/A | N/A |
Market Valuation Indicators
| 2024/06 - Interim | %Chg (Compare to Interim) | 2023/06 | 2022/06 | 2021/06 | 2020/06 | |
| EPS (cts) | 34.000 | 9.677% | 31.000 | 19.000 | 16.000 | 9.000 |
| DPS (cts) | 5.000 | -- | 0.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | 14.706% | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | -- | -- | -- | -- |
| NBV per share ($) | 4.758 | -- | 4.596 | -- | 4.797 | 4.552 |
| Remarks: | Real time quote last updated: 01/11/2024 18:00 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 433,949 |
| %Change | 9.121% |
| EPS / (LPS) | RMB 0.340 |
| NBV Per Share (¥) | RMB 4.758 |